Artificial Intelligence-Based Assessment of Cognitive Impairment in Neurodegenerative Diseases

Wed18  Apr03:40pm(30 mins)
The Boulind Suite
 Seyed-Mahdi  Khaligh-Razavi


Neurodegenerative disorders, such as Alzheimer’s disease, continue to represent a major economic, social and healthcare burden. These diseases remain underdiagnosed or are diagnosed too late for meaningful interventions. The development of screening tests capable of detecting neurodegenerative diseases during early, preferably asymptomatic, stages has been a highly unmet need. Since such tests will be used for screening large populations of people, they should be non-invasive, inexpensive, and ideally independent of language, education, culture and practice. Taking advantage of new AI and machine learning techniques, we have developed a 5-minute integrated cognitive assessment tool (ICA) that meets these criteria, and can learn from new data to improve itself. The test can be additionally used for monitoring the progression of the disease or effectiveness of the treatments.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021